TY - JOUR
T1 - SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission
T2 - living systematic review and meta-analysis
AU - PregCOV-19 Living Systematic Review Consortium
AU - Allotey, John
AU - Kew, Tania
AU - Fernández-García, Silvia
AU - Gaetano-Gil, Andrea
AU - Yap, Magnus
AU - Sheikh, Jameela
AU - Littmoden, Megan
AU - Akande, Oluwadamilola
AU - Khalil, Halimah
AU - Kumaran, Maurie
AU - Barry, Kathryn
AU - Attarde, Shruti
AU - Sambamoorthi, Dharshini
AU - Ramkumar, Anoushka
AU - Lawson, Heidi
AU - Manning, Millie
AU - Maddock, Sophie
AU - Gupta, Ankita
AU - Hebbar, Meghnaa
AU - Khashaba, Alya
AU - Ansari, Kehkashan
AU - Banjoko, Adeolu
AU - Walker, Kate
AU - O’Donoghue, Keelin
AU - van Wely, Madelon
AU - van Leeuwen, Elizabeth
AU - Kostova, Elena
AU - Kunst, Heinke
AU - Khalil, Asma
AU - Brizuela, Vanessa
AU - Kara, Edna
AU - Kim, Caron Rahn
AU - Thorson, Anna
AU - Oladapo, Olufemi T.
AU - Zamora, Javier
AU - Bonet, Mercedes
AU - Mofenson, Lynne
AU - Thangaratinam, Shakila
AU - Pecks, Ulrich
AU - Ruediger, Mario
AU - Tong, Van T.
AU - Ellington, Sascha
AU - Nair, Ajith Sreedharan
AU - Caradeux, Javier
AU - Monckeberg, Max
AU - Khoury, Rasha
AU - Marín Gabriel, Miguel Ángel
AU - Ayed, Mariam
AU - Broutet, Nathalie
AU - Stallings, Elena
N1 - Publisher Copyright:
© 2022 BMJ Publishing Group. All rights reserved.
PY - 2022
Y1 - 2022
N2 - OBJECTIVES To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring. DESIGN Living systematic review and meta-analysis. DATA SOURCES Major databases between 1 December 2019 and 25 April 2022. STUDY SELECTION Cohort studies of pregnant and recently pregnant women (including after abortion or miscarriage) who sought hospital care for any reason and had a diagnosis of SARS-CoV-2 infection, and also provided data on offspring SARS-CoV-2 status and risk factors for positivity. Case series and case reports were also included to assess the timing and likelihood of mother-to-child transmission in SARS-CoV-2 positive babies. DATA EXTRACTION Two reviewers independently extracted data and assessed study quality. A random effects model was used to synthesise data for rates, with associations reported using odds ratios and 95% confidence intervals. Narrative syntheses were performed when meta-analysis was inappropriate. The World Health Organization classification was used to categorise the timing of mother-to-child transmission (in utero, intrapartum, early postnatal). RESULTS 643 studies (343 cohort studies, 300 case series and case reports; 44 552 mothers, 30 822 babies) were included. Overall, 2.7% (95% confidence interval 2.1% to 3.5%; 210 studies, 24 040 babies) born to mothers with SARS-CoV-2 infection tested positive for the virus with reverse transcriptase polymerase chain reaction (RT-PCR). Of the 1107 SARS-CoV-2 positive babies with data on the timing of exposure and type and timing of tests, 32 had confirmed mother-to-child transmission: 20 in utero (857 assessed), three intrapartum (35 assessed), and nine during the early postnatal period (144 assessed). Of the 1213 SARS-CoV-2 positive babies with outcome data, 64 were stillbirths, 36 were neonatal deaths, and nine were early pregnancy losses; 1104 babies were alive at the end of followup. Severe maternal covid-19 (odds ratio 3.5, 95% confidence interval 1.5 to 8.1), maternal death (14.1, 4.1 to 48.0), maternal postnatal infection (5.0, 1.2 to 20.1), caesarean section (1.4, 1.1 to 1.8), and preterm delivery (1.5, 1.2 to 1.9) were associated with SARS-CoV-2 positivity in offspring. Positivity rates in offspring using RT-PCR varied between regions, ranging from 0.1% (95% confidence interval 0.0% to 0.5%) in studies from North America to 8.5% (4.6% to 13.3%) in studies from Latin America and the Caribbean. CONCLUSION SARS-CoV-2 positivity rates are low in babies born to mothers with SARS-CoV-2 infection. Evidence confirms vertical transmission of SARS-CoV-2, although this is rare. Severity of maternal covid-19 is associated with SARS-CoV-2 positivity in offspring.
AB - OBJECTIVES To assess the rates of SARS-CoV-2 positivity in babies born to mothers with SARS-CoV-2 infection, the timing of mother-to-child transmission and perinatal outcomes, and factors associated with SARS-CoV-2 status in offspring. DESIGN Living systematic review and meta-analysis. DATA SOURCES Major databases between 1 December 2019 and 25 April 2022. STUDY SELECTION Cohort studies of pregnant and recently pregnant women (including after abortion or miscarriage) who sought hospital care for any reason and had a diagnosis of SARS-CoV-2 infection, and also provided data on offspring SARS-CoV-2 status and risk factors for positivity. Case series and case reports were also included to assess the timing and likelihood of mother-to-child transmission in SARS-CoV-2 positive babies. DATA EXTRACTION Two reviewers independently extracted data and assessed study quality. A random effects model was used to synthesise data for rates, with associations reported using odds ratios and 95% confidence intervals. Narrative syntheses were performed when meta-analysis was inappropriate. The World Health Organization classification was used to categorise the timing of mother-to-child transmission (in utero, intrapartum, early postnatal). RESULTS 643 studies (343 cohort studies, 300 case series and case reports; 44 552 mothers, 30 822 babies) were included. Overall, 2.7% (95% confidence interval 2.1% to 3.5%; 210 studies, 24 040 babies) born to mothers with SARS-CoV-2 infection tested positive for the virus with reverse transcriptase polymerase chain reaction (RT-PCR). Of the 1107 SARS-CoV-2 positive babies with data on the timing of exposure and type and timing of tests, 32 had confirmed mother-to-child transmission: 20 in utero (857 assessed), three intrapartum (35 assessed), and nine during the early postnatal period (144 assessed). Of the 1213 SARS-CoV-2 positive babies with outcome data, 64 were stillbirths, 36 were neonatal deaths, and nine were early pregnancy losses; 1104 babies were alive at the end of followup. Severe maternal covid-19 (odds ratio 3.5, 95% confidence interval 1.5 to 8.1), maternal death (14.1, 4.1 to 48.0), maternal postnatal infection (5.0, 1.2 to 20.1), caesarean section (1.4, 1.1 to 1.8), and preterm delivery (1.5, 1.2 to 1.9) were associated with SARS-CoV-2 positivity in offspring. Positivity rates in offspring using RT-PCR varied between regions, ranging from 0.1% (95% confidence interval 0.0% to 0.5%) in studies from North America to 8.5% (4.6% to 13.3%) in studies from Latin America and the Caribbean. CONCLUSION SARS-CoV-2 positivity rates are low in babies born to mothers with SARS-CoV-2 infection. Evidence confirms vertical transmission of SARS-CoV-2, although this is rare. Severity of maternal covid-19 is associated with SARS-CoV-2 positivity in offspring.
UR - https://www.scopus.com/pages/publications/85126697409
U2 - 10.1136/bmj-2021-067696
DO - 10.1136/bmj-2021-067696
M3 - Article
C2 - 35296519
AN - SCOPUS:85126697409
SN - 0959-8146
VL - 376
JO - BMJ
JF - BMJ
M1 - e067696
ER -